Literature DB >> 11594577

Pegylated doxorubicin for primary cutaneous T cell lymphoma: a report on ten patients with follow-up.

U Wollina1, T Graefe, M Kaatz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594577

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

Review 1.  New targets of therapy in T-cell lymphomas.

Authors:  Jack Erter; Lapo Alinari; Kamruz Darabi; Metin Gurcan; Ramiro Garzon; Guido Marcucci; Mark A Bechtel; Henry Wong; Pierluigi Porcu
Journal:  Curr Drug Targets       Date:  2010-04       Impact factor: 3.465

Review 2.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

3.  [Cutaneous lymphoma].

Authors:  M Beyeler; G Burg; R Dummer
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.